Burcon NutraScience Corporation (TSX:BU)
Canada
· Delayed Price · Currency is CAD 2.380
-0.030 (-1.24%)
At close: Mar 6, 2026
Burcon NutraScience Income Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 1.48 | 0.38 | 0.18 | 0.36 | 0.17 | 0.26 | Upgrade
|
| Revenue Growth (YoY) | 337.52% | 106.88% | -49.34% | 112.23% | -33.70% | 730.75% | Upgrade
|
| Cost of Revenue | 6.81 | 1.25 | - | - | - | 0.79 | Upgrade
|
| Gross Profit | -5.33 | -0.87 | 0.18 | 0.36 | 0.17 | -0.53 | Upgrade
|
| Selling, General & Admin | 3.15 | 3.9 | 3.74 | 3.94 | 4.53 | 3.8 | Upgrade
|
| Research & Development | 1.51 | 2.92 | 3.46 | 3.95 | 3.38 | 0.53 | Upgrade
|
| Operating Expenses | 4.66 | 6.83 | 7.2 | 7.89 | 7.91 | 4.33 | Upgrade
|
| Operating Income | -9.98 | -7.7 | -7.02 | -7.53 | -7.74 | -4.86 | Upgrade
|
| Interest Expense | -2.76 | -0.63 | -0.41 | -0.2 | -0.06 | -0.7 | Upgrade
|
| Interest & Investment Income | 0.15 | 0.08 | 0.09 | 0.41 | 0.41 | 0.45 | Upgrade
|
| Earnings From Equity Investments | - | - | - | -5.5 | -4.29 | -2.42 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.29 | 0.02 | -0 | 0 | -0 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.03 | -0.03 | -0.1 | -0.27 | 0.11 | 0.27 | Upgrade
|
| EBT Excluding Unusual Items | -12.91 | -8.26 | -7.45 | -13.08 | -11.59 | -7.26 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -7.99 | 0.96 | 6.38 | Upgrade
|
| Other Unusual Items | - | - | - | -4.36 | 0.34 | 0.26 | Upgrade
|
| Pretax Income | -12.91 | -8.26 | -7.45 | -25.42 | -10.29 | -0.62 | Upgrade
|
| Income Tax Expense | - | - | - | -0.06 | -0.03 | - | Upgrade
|
| Net Income | -12.91 | -8.26 | -7.45 | -25.36 | -10.26 | -0.62 | Upgrade
|
| Net Income to Common | -12.91 | -8.26 | -7.45 | -25.36 | -10.26 | -0.62 | Upgrade
|
| Shares Outstanding (Basic) | 12 | 8 | 6 | 5 | 5 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 12 | 8 | 6 | 5 | 5 | 5 | Upgrade
|
| Shares Change (YoY) | 73.57% | 28.83% | 11.65% | 0.13% | 5.54% | 30.35% | Upgrade
|
| EPS (Basic) | -1.08 | -1.06 | -1.23 | -4.67 | -1.89 | -0.12 | Upgrade
|
| EPS (Diluted) | -1.08 | -1.06 | -1.23 | -4.67 | -1.89 | -0.12 | Upgrade
|
| Free Cash Flow | -8.12 | -5.82 | -5.9 | -6.38 | -5.97 | -3.93 | Upgrade
|
| Free Cash Flow Per Share | -0.68 | -0.74 | -0.97 | -1.17 | -1.10 | -0.76 | Upgrade
|
| Gross Margin | - | -228.31% | 100.00% | 100.00% | 100.00% | -203.87% | Upgrade
|
| Operating Margin | -673.98% | -2018.75% | -3807.23% | -2067.88% | -4512.57% | -1877.56% | Upgrade
|
| Profit Margin | -871.55% | -2166.98% | -4038.96% | -6969.87% | -5982.59% | -238.74% | Upgrade
|
| Free Cash Flow Margin | -548.04% | -1525.02% | -3202.50% | -1751.91% | -3478.73% | -1518.48% | Upgrade
|
| EBITDA | -8.93 | -7.43 | -6.8 | -7.29 | -7.58 | -4.73 | Upgrade
|
| D&A For EBITDA | 1.06 | 0.26 | 0.22 | 0.24 | 0.16 | 0.12 | Upgrade
|
| EBIT | -9.98 | -7.7 | -7.02 | -7.53 | -7.74 | -4.86 | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 0.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.